Monte Rosa Therapeutics, Inc. Common Stock
Symbol: GLUE (NASDAQ)
Company Description:
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.
- Today's Open: $7.56
- Today's High: $7.785
- Today's Low: $7.44
- Today's Volume: 268.70K
- Yesterday Close: $7.5
- Yesterday High: $7.728
- Yesterday Low: $7.36
- Yesterday Volume: 896.38K
- Last Min Volume: 1.36K
- Last Min High: $7.519
- Last Min Low: $7.497
- Last Min VWAP: $7.5071
- Name: Monte Rosa Therapeutics, Inc. Common Stock
- Website: https://www.monterosatx.com
- Listed Date: 2021-06-24
- Location: BOSTON, MA
- Market Status: Active
- CIK Number: 0001826457
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $463.20M
- Round Lot: 100
- Outstanding Shares: 61.76M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-15 | 8-K | View |
| 2025-08-21 | UPLOAD | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-22 | CORRESP | View |
| 2025-07-15 | UPLOAD | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-06-06 | SCHEDULE 13G/A | View |
| 2025-06-04 | 4 | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-08 | 10-Q | View |
| 2025-05-08 | 8-K | View |